2-148463758-G-A
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_001378120.1(MBD5):c.236G>A(p.Gly79Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000868 in 1,613,622 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G79V) has been classified as Uncertain significance.
Frequency
Consequence
NM_001378120.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MBD5 | NM_001378120.1 | c.236G>A | p.Gly79Glu | missense_variant | 7/14 | ENST00000642680.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MBD5 | ENST00000642680.2 | c.236G>A | p.Gly79Glu | missense_variant | 7/14 | NM_001378120.1 |
Frequencies
GnomAD3 genomes AF: 0.000599 AC: 91AN: 152032Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000583 AC: 146AN: 250446Hom.: 1 AF XY: 0.000561 AC XY: 76AN XY: 135514
GnomAD4 exome AF: 0.000896 AC: 1309AN: 1461472Hom.: 1 Cov.: 31 AF XY: 0.000889 AC XY: 646AN XY: 727052
GnomAD4 genome AF: 0.000598 AC: 91AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.000605 AC XY: 45AN XY: 74398
ClinVar
Submissions by phenotype
Intellectual disability, autosomal dominant 1 Uncertain:1Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Apr 11, 2024 | BS1, BS2, BS4 - |
Uncertain significance, flagged submission | clinical testing | Fulgent Genetics, Fulgent Genetics | May 23, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
not provided Uncertain:1Benign:3
Uncertain significance, flagged submission | clinical testing | Eurofins Ntd Llc (ga) | Jan 16, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 13, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 02, 2019 | This variant is associated with the following publications: (PMID: 27222293, 21981781, 23055267) - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | MBD5: BS1 - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 05, 2024 | The p.Gly79Glu variant in MBD5 is classified as likely benign because it has been identified in 0.1% (75/68004) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org, v.3.1.2). ACMG/AMP Criteria applied: BS1. - |
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 21, 2015 | - - |
MBD5 associated neurodevelopmental disorder Pathogenic:1
Likely pathogenic, flagged submission | research | Elsea Laboratory, Baylor College of Medicine | Oct 01, 2012 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
MBD5-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 19, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at